HeartFlow Inc. (NASDAQ: HTFL) received U.S. Food and Drug Administration 510(k) clearance for its next-generation plaque analysis platform and announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE